Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of AminoIndex™ (Amino Metabolomic) As Biomarkers for Gynecologic Cancer in the U. S. Population

NCT02178462 is registered in ClinicalTrials.gov with Ajinomoto Co., Inc. as lead sponsor.

NCT NCT02178462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02178462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of AminoIndex™ (Amino Metabolomic) As Biomarkers for Gynecologic Cancer in the U. S. Population
Lead sponsor
Ajinomoto Co., Inc.
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2014
Completion date
March 31, 2018
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign gynecological disease, endometrial cancer, ovarian cancer